Advanced Search
Contact | Corporate | Help

CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer

Sponsors:
  • Dana-Farber Cancer Institute
  • Brigham and Women's Hospital
  • Massachusetts General Hospital
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Esophageal Cancer
  • Gastric Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: bevacizumab
  • Drug: trastuzumab
  • Drug: oxaliplatin
  • Drug: capecitabine
Enrollment:
36

Additional information about NCT01191697.


SourceSolution © 2008-2012